Assessment of the levels of some prognostic biomolecules (galectins, ACE2, SCUBE1/2/3) in COVID-19 patients

Future Microbiol. 2023 Dec:18:1329-1337. doi: 10.2217/fmb-2023-0099. Epub 2023 Nov 1.

Abstract

Aim: Our aim was to investigate the differences between healthy people and COVID-19 patients in terms of some immunological biomolecules, especially including those related to the inflammation process. Materials & methods: A total of 180 participants (90 healthy controls and 90 COVID-19 patients) were included. The expression levels of eight different inflammation-related biomolecules were measured by the ELISA technique. Results: The mean levels of ACE2, ANG1-7, GAL3, GAL9, SCUBE1, SCUBE2 and SCUBE3 were elevated in COVID-19 patients when compared with healthy controls, while the mean level of GAL2 was lower in COVID-19 patients than controls. Conclusion: To understand the cytokine storm mechanism and related parameters, more detailed studies should be performed investigating more related biomolecules and related signaling pathways.

Keywords: ACE2; COVID-19; SARS-CoV-2; SCUBE; galectins; inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Angiotensin-Converting Enzyme 2
  • COVID-19*
  • Calcium-Binding Proteins
  • Galectins
  • Humans
  • Inflammation
  • Prognosis
  • SARS-CoV-2

Substances

  • Angiotensin-Converting Enzyme 2
  • Galectins
  • SCUBE1 protein, human
  • Calcium-Binding Proteins
  • SCUBE2 protein, human
  • Adaptor Proteins, Signal Transducing
  • SCUBE3 protein, human